Jessica Fink, DPM
Foot & Ankle Surgery · Florence, SCNPI 1619350162
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Peerless Surgical Inc. at 25.6% of the total. Reporting peaked in 2020 at $1,916 and has fallen 73.2% since, to $513 in 2025.
Across 121 payments — averaging $56.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Peerless Surgical Inc.$2K
- Integra Lifesciences Corporation$1K
- Orthofix Medical, Inc.$1K
- Stryker$515
- Treace Medical Concepts, Inc.$340
- Amgen$247
- plus $2K from 27 others
What the payments were for
- Travel & lodging$2,18832%
- Food & beverage$2,88742%
- Education$1,74326%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Peerless Surgical Inc. | 2 | $1,743 |
| Integra Lifesciences Corporation | 16 | $1,245 |
| Orthofix Medical, Inc. | 9 | $1,079 |
| Stryker | 9 | $515 |
| Treace Medical Concepts, Inc. | 5 | $340 |
| Amgen(2 entities) | 10 | $247 |
| Organogenesis Inc. | 4 | $189 |
| Smith+Nephew | 6 | $183 |
| Paratek Pharmaceuticals, Inc. | 7 | $139 |
| Musculoskeletal Transplant Foundation Inc. | 6 | $130 |
| Epsfl, LLC | 1 | $125 |
| AbbVie(2 entities) | 6 | $103 |
| Boston Scientific | 5 | $95 |
| Bioventus LLC | 4 | $82 |
| Kerecis Limited | 2 | $70 |
| Kowa Pharmaceuticals America, Inc. | 4 | $62 |
| Baxter Healthcare | 2 | $55 |
| Cashflow Solutions, LLC | 4 | $49 |
| Kuros Biosciences USA, Inc | 1 | $42 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| Acell, Inc. | 2 | $38 |
| Nabriva Therapeutics, PLC | 2 | $37 |
| Nevro Corp. | 2 | $33 |
| GRT US Holding, Inc. | 1 | $31 |
| Polynovo North America LLC | 1 | $28 |
| Convatec Inc. | 1 | $27 |
| Zimmer Biomet | 1 | $17 |
| Triad Life Sciences Inc. | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Sebela Pharmaceuticals Inc. | 1 | $11 |
| ERMI LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,819 in reported general payments places this provider in the 65th percentile of 87 foot & ankle surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 22 | $20,845 |
| SantylCollagenase Clostridium Hist. | 12 | $5,428 |
| Ketoconazole | 142 | $3,065 |
| Clotrimazole | 86 | $2,794 |
| Ciclopirox | 79 | $2,469 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 59 | $1,770 |
| Ammonium Lactate | 76 | $1,667 |
| Terbinafine Hcl | 48 | $995 |
| Gabapentin | 85 | $893 |
| Methylprednisolone | 94 | $726 |
| Celecoxib | 30 | $455 |
| Etodolac | 11 | $441 |
| Diclofenac Sodium | 21 | $367 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 28 | $366 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $183 | $5,42812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 87 foot & ankle surgery providers in South Carolina.
Other foot & ankle surgery in Florence
- Jason OdellFlorence$46K
- Paul WeatherbyFlorence$23K
- Christopher TyreeFlorence$21K
- Misty LeeFlorence$19K
- Benjamin OverleyHilton Head Island$643K
- Tyler GonzalezColumbia$525K
- Alison GartenRock Hill$419K
- Christopher GrossCharleston$394K
- Robert KleinGreenville$358K
- William JamesColumbia$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.